Title: | √Assessment and Management of Antinuclear Antibodies positive population |
Edition: | Original |
Classification: | Patient version of guideline |
Field: | |
Countries and regions: | China |
Guidelines users: | |
Evidence classification method: | GRADE |
Development unit: | Guangdong Provincial Clinical Research Center for Immunological Diseases |
Registration time: | 2020-09-11 |
Registration number: | IPGRP-2020CN158 |
Purpose of the guideline: |